Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PSYCHIATRIC MANAGEMENT, LLC

NPI: 1043870199 · LAS VEGAS, NV 89146 · Pain Medicine Physician · NPI assigned 06/19/2019

$1.40M
Total Medicaid Paid
25,850
Total Claims
18,793
Beneficiaries
11
Codes Billed
2019-08
First Month
2021-11
Last Month

Provider Details

Authorized OfficialLINDEN, DAVID (OWNER)
NPI Enumeration Date06/19/2019

Related Entities

Other providers sharing the same authorized official: LINDEN, DAVID

ProviderCityStateTotal Paid
PSYCHIATRIC MANAGEMENT, LLC LAS VEGAS NV $4.59M
SILVER STATE HEALTH CARE SERVICES, LLC LAS VEGAS NV $1.38M
LINDEN & ASSOCIATES PC LAS VEGAS NV $1.13M
MIND BODY SOLUTIONS PHYSICAL THERAPY, LLC LAS VEGAS NV $190K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 3,199 $151K
2020 10,341 $590K
2021 12,310 $664K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8,483 5,838 $702K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 6,839 4,895 $321K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,889 3,256 $147K
Q3014 Telehealth originating site facility fee 4,759 3,111 $110K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 1,114 987 $85K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 366 345 $11K
99354 197 167 $10K
99215 Prolong outpt/office vis 124 119 $9K
99205 Prolong outpt/office vis 48 48 $8K
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit 18 15 $1K
99407 13 12 $0.00